Key Points
- COO Matthew Fraser Ahearn sold 8,314 Shoulder Innovations shares at an average price of $20.10, generating $167,111.40. The transaction was made under a pre-arranged Rule 10b5-1 plan, leaving him with 258,362 shares.
- Shoulder Innovations reported quarterly revenue of $17.18 million and an adjusted loss of $0.49 per share, missing the consensus estimate of a $0.46 loss. Analysts expect the company to post a full-year loss of approximately $1.90 per share.
- Analysts remain broadly positive, with six Buy ratings, one Hold and one Sell; the stock has a “Moderate Buy” consensus rating and a $23.50 average price target.
Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) COO Matthew Fraser Ahearn sold 8,314 shares of Shoulder Innovations stock in a transaction on Monday, August 17th. The shares were sold at an average price of $20.10, for a total transaction of $167,111.40. Following the completion of the sale, the chief operating officer owned 258,362 shares of the company's stock, valued at $5,193,076.20. This represents a 3.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Matthew Fraser Ahearn also recently made the following trade(s):
- On Tuesday, August 18th, Matthew Fraser Ahearn sold 14,186 shares of Shoulder Innovations stock. The shares were sold at an average price of $20.99, for a total transaction of $297,764.14.
- On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The stock was sold at an average price of $18.84, for a total transaction of $78,072.96.
- On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.68, for a total transaction of $296,190.08.
Shoulder Innovations Price Performance
Shares of NYSE SI opened at $21.09 on Wednesday. The firm has a market capitalization of $439.16 million and a P/E ratio of -10.99. The firm's 50-day moving average price is $20.72 and its 200-day moving average price is $16.37. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12. Shoulder Innovations, Inc. has a 1-year low of $10.92 and a 1-year high of $24.59.
Shoulder Innovations (NYSE:SI - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.03). Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. The firm had revenue of $17.18 million during the quarter. Equities research analysts anticipate that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several research firms have recently commented on SI. UBS Group boosted their price objective on Shoulder Innovations from $27.00 to $28.00 and gave the company a "buy" rating in a report on Monday, August 10th. Piper Sandler reissued an "overweight" rating and issued a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a research report on Friday, August 7th. BTIG Research boosted their price target on shares of Shoulder Innovations from $24.00 to $26.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Finally, Weiss Ratings upgraded shares of Shoulder Innovations from a "sell (d-)" rating to a "sell (d)" rating in a report on Monday, August 3rd. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $23.50.
Check Out Our Latest Stock Analysis on Shoulder Innovations
Hedge Funds Weigh In On Shoulder Innovations
A number of hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Shoulder Innovations during the 3rd quarter worth approximately $28,000. Compass Financial Management LLC bought a new position in shares of Shoulder Innovations in the second quarter valued at approximately $30,000. Rhumbline Advisers purchased a new position in shares of Shoulder Innovations during the third quarter valued at approximately $54,000. Wells Fargo & Company MN boosted its position in shares of Shoulder Innovations by 66.3% during the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company's stock valued at $75,000 after buying an additional 2,094 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new stake in Shoulder Innovations during the fourth quarter worth $176,000.
About Shoulder Innovations
(
Get Free Report)
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
